10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 254 filers reported holding 10X GENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,619,302 | -72.2% | 63,498 | -62.4% | 0.02% | -69.8% |
Q2 2023 | $9,428,553 | +47.8% | 168,849 | -3.5% | 0.06% | +70.3% |
Q4 2022 | $6,378,749 | -2.8% | 175,048 | -24.0% | 0.04% | 0.0% |
Q3 2022 | $6,563,000 | -18.3% | 230,447 | +29.8% | 0.04% | -24.5% |
Q2 2022 | $8,032,000 | -17.9% | 177,506 | +38.0% | 0.05% | -41.0% |
Q1 2022 | $9,784,000 | +2428.2% | 128,616 | +4850.6% | 0.08% | +1975.0% |
Q4 2021 | $387,000 | -52.2% | 2,598 | -53.3% | 0.00% | -60.0% |
Q3 2021 | $810,000 | -73.6% | 5,566 | -64.5% | 0.01% | -71.4% |
Q2 2021 | $3,070,000 | +23515.4% | 15,680 | +21379.5% | 0.04% | – |
Q1 2021 | $13,000 | -99.6% | 73 | -99.7% | 0.00% | -100.0% |
Q4 2020 | $3,441,000 | -28.1% | 24,301 | -36.7% | 0.05% | -33.8% |
Q3 2020 | $4,788,000 | +449.1% | 38,403 | +293.2% | 0.07% | +373.3% |
Q2 2020 | $872,000 | +17340.0% | 9,766 | +11956.8% | 0.02% | – |
Q1 2020 | $5,000 | -98.0% | 81 | -97.5% | 0.00% | -100.0% |
Q4 2019 | $249,000 | +322.0% | 3,264 | +177.3% | 0.01% | +400.0% |
Q3 2019 | $59,000 | – | 1,177 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |